NKGen Biotech, Inc.
NKGNDelisted Jul 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001845459
NKGen Biotech, Inc. was delisted on Jul 17, 2025; its insiders filed their last Form 4 on Jun 2, 2025; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding NKGen Biotech, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 17 | 1 | 19 | +3 |
| Shares | 3.42M | 17.0K | 3.75M | +353.7K (+10.4%) |
| Value | $4.24M | $21.5K | $1.23M | −$2.99M (−70.9%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held NKGen Biotech, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 95,438 | $36.1K | 0.00% |
| Two Sigma Securities, LLC | 24,475 | $9.25K | 0.00% |
| BlackRock, Inc. | 1,854 | $701 | 0.00% |
| JPMorgan Chase & Co | 31 | $12 | 0.00% |
Sold out (1)
Institutions that held NKGen Biotech, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Virtu Financial LLC | 18,917 | $24.0K |
Not filed for Q3 2024 yet (1)
Institutions that held NKGen Biotech, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 16,966 | $21.5K |